The effects of L-tryptophan on haloperidol-induced movement disorder in the rat

Laura Kozell, Reuven Sandyk, George Wagner, Hans Fisher

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

An animal model of haloperidol-induced tardive dyskinesia was studied in relation to the dietary manipulation of tryptophan and its effect on the movement disorder. This study showed a significant negative behavioral response to the neuroleptic drug, haloperidol. Increased dietary tryptophan (1.0 vs. 0.3%) significantly reduced the frequency of drug-induced head movements. Brain serotonin levels were elevated by the drug treatment. Brain serotonin levels correlated significantly with the behavioral response. Contrary to expectation, brain dopamine levels did not correlate with the behavioral response. These findings suggest a possible serotonergic involvement in neuroleptic-induced tardive dyskinesia and an amelioration of the disorder through tryptophan supplementation.

Original languageEnglish (US)
Pages (from-to)1739-1744
Number of pages6
JournalLife Sciences
Volume41
Issue number14
DOIs
StatePublished - Oct 5 1987

Fingerprint

Movement Disorders
Haloperidol
Tryptophan
Rats
Brain
Antipsychotic Agents
Serotonin
Drug therapy
Head Movements
Pharmaceutical Preparations
Dopamine
Animals
Animal Models
Tardive Dyskinesia

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kozell, Laura ; Sandyk, Reuven ; Wagner, George ; Fisher, Hans. / The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. In: Life Sciences. 1987 ; Vol. 41, No. 14. pp. 1739-1744.
@article{cbce676222fa41dfa4a609d90fe139e0,
title = "The effects of L-tryptophan on haloperidol-induced movement disorder in the rat",
abstract = "An animal model of haloperidol-induced tardive dyskinesia was studied in relation to the dietary manipulation of tryptophan and its effect on the movement disorder. This study showed a significant negative behavioral response to the neuroleptic drug, haloperidol. Increased dietary tryptophan (1.0 vs. 0.3{\%}) significantly reduced the frequency of drug-induced head movements. Brain serotonin levels were elevated by the drug treatment. Brain serotonin levels correlated significantly with the behavioral response. Contrary to expectation, brain dopamine levels did not correlate with the behavioral response. These findings suggest a possible serotonergic involvement in neuroleptic-induced tardive dyskinesia and an amelioration of the disorder through tryptophan supplementation.",
author = "Laura Kozell and Reuven Sandyk and George Wagner and Hans Fisher",
year = "1987",
month = "10",
day = "5",
doi = "10.1016/0024-3205(87)90602-3",
language = "English (US)",
volume = "41",
pages = "1739--1744",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "14",

}

The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. / Kozell, Laura; Sandyk, Reuven; Wagner, George; Fisher, Hans.

In: Life Sciences, Vol. 41, No. 14, 05.10.1987, p. 1739-1744.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effects of L-tryptophan on haloperidol-induced movement disorder in the rat

AU - Kozell, Laura

AU - Sandyk, Reuven

AU - Wagner, George

AU - Fisher, Hans

PY - 1987/10/5

Y1 - 1987/10/5

N2 - An animal model of haloperidol-induced tardive dyskinesia was studied in relation to the dietary manipulation of tryptophan and its effect on the movement disorder. This study showed a significant negative behavioral response to the neuroleptic drug, haloperidol. Increased dietary tryptophan (1.0 vs. 0.3%) significantly reduced the frequency of drug-induced head movements. Brain serotonin levels were elevated by the drug treatment. Brain serotonin levels correlated significantly with the behavioral response. Contrary to expectation, brain dopamine levels did not correlate with the behavioral response. These findings suggest a possible serotonergic involvement in neuroleptic-induced tardive dyskinesia and an amelioration of the disorder through tryptophan supplementation.

AB - An animal model of haloperidol-induced tardive dyskinesia was studied in relation to the dietary manipulation of tryptophan and its effect on the movement disorder. This study showed a significant negative behavioral response to the neuroleptic drug, haloperidol. Increased dietary tryptophan (1.0 vs. 0.3%) significantly reduced the frequency of drug-induced head movements. Brain serotonin levels were elevated by the drug treatment. Brain serotonin levels correlated significantly with the behavioral response. Contrary to expectation, brain dopamine levels did not correlate with the behavioral response. These findings suggest a possible serotonergic involvement in neuroleptic-induced tardive dyskinesia and an amelioration of the disorder through tryptophan supplementation.

UR - http://www.scopus.com/inward/record.url?scp=0023583719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023583719&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(87)90602-3

DO - 10.1016/0024-3205(87)90602-3

M3 - Article

C2 - 3657380

AN - SCOPUS:0023583719

VL - 41

SP - 1739

EP - 1744

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 14

ER -